SOUTH SAN FRANCISCO, Calif., & PARIS--(BUSINESS WIRE)--DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) and DNA on demand, has been named to Fast Company’s prestigious annual list of the ...

DNA Script was created to revolutionize DNA writing with enzymes. Their core research and development efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries and ...

SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) and DNA printing on demand, today announced it has raised $165 million in a Series C ...

DNA Script announced a significant advancement in oligonucleotide synthesis technology, enabling the production of custom DNA sequences of up to 500 nucleotides in length with unprecedented sequence ...

DNA Script will receive up to $9.35 million to leverage the company's novel enzymatic DNA synthesis (EDS) technology for the project This is the second announced project[1] where DNA Script has been ...

The SYNTAX System Delivers DNA On Demand to Enable Labs to Control Their Workflow, Innovate Faster SOUTH SAN FRANCISCO, Calif., and PARIS, May 20, 2021 /PRNewswire/ -- DNA Script, a leading pioneer in ...

SOUTH SAN FRANCISCO, Calif. and PARIS, June 15, 2021 /PRNewswire/ -- DNA Script, a pioneer in DNA printing on demand, today announced the commercial launch of their SYNTAX platform with their first ...

With a $5 million grant from DARPA, DNA Script and Moderna will develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of the DARPA’s Nucleic Acids On-Demand ...

Company will receive up to $5 Million in grant funds from DARPA as part of the agency's Nucleic Acids On-Demand World-Wide Program to plan for and prevent the next viral pandemic SOUTH SAN FRANCISCO, ...

Following the launch of its benchtop DNA printer earlier this year, DNA Script has secured a hefty $165 million to take its platform to the masses. The nine-digit proceeds represent a big leap in DNA ...

DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is the first big leap forward in manufacturing genetic material. The revolution in synthetic biology that ...

Synthesising DNA for Bio Science research and development is costly in terms of time and resources. It’s also a fast-growing, big business. The global Gene Synthesis market will reach over $21 billion ...